SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review

Published:2017-03 Issue: Volume:304 Page:29-34
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Nimmagadda Vamshi K.C.,Makar Tapas K.,Chandrasekaran Krish,Sagi Avinash Rao,Ray Jayanta,Russell James W.,Bever Christopher T.

Funder

Biomedical and Laboratory R&D

National MS Society

Rehabilitation R&D and Biomedical and Laboratory R&D

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference75 articles.

1. NAD(+)-SIRT1 control of H3K4 trimethylation through circadian deacetylation of MLL1;Aguilar-Arnal;Nat. Struct. Mol. Biol.,2015

2. NMNATs, evolutionarily conserved neuronal maintenance factors;Ali;Trends Neurosci.,2013

3. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration;Araki;Science,2004

4. SIRT1 regulates circadian clock gene expression through PER2 deacetylation;Asher;Cell,2008

5. The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction;Babetto;Cell Rep.,2013

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are Sirtuins 1 and 2 Relevant Players in Relapsing–Remitting Multiple Sclerosis?;Biomedicines;2024-09-05

2. A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis;International Journal of Molecular Sciences;2024-08-16

3. Anemonin ameliorates human diploid fibroblasts 2BS and IMR90 cell senescence by PARP1-NAD+-SIRT1 signaling pathway;Archives of Gerontology and Geriatrics;2024-02

4. Salvianolic acid A alleviates cardiovascular injury in rats with chronic kidney disease by activating the PI3K/Akt/Nrf2/HO-1 and SIRT1/TLR4/NF-κB/P38 signaling pathways;Journal of Functional Foods;2023-11

5. A Mechanism Underpinning the Bioenergetic Metabolism‐Regulating Function of Gold Nanocatalysts;Small;2023-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3